Financial Consulate’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.32M Hold
156,457
0.41% 25
2025
Q4
$2.55M Hold
156,457
0.35% 28
2025
Q3
$1.83M Buy
+156,457
New +$2.04M 0.26% 31
2023
Q2
Sell
-156,457
Closed -$8.73M 108
2023
Q1
$8.73M Hold
156,457
3.05% 9
2022
Q4
$5.7M Buy
156,457
+1,515
+1% +$49.5K 1.99% 11
2022
Q3
$4.41M Hold
154,942
1.86% 10
2022
Q2
$7.01M Hold
154,942
3.29% 9
2022
Q1
$11.8M Hold
154,942
4.53% 8
2021
Q4
$23.1M Buy
154,942
+339
+0.2% +$51.9K 8% 2
2021
Q3
$22.5M Buy
154,603
+13,345
+9% +$2.29M 8.16% 3
2021
Q2
$27.7M Sell
141,258
-17,500
-11% -$3.17M 9.97% 1
2021
Q1
$28.7M Sell
158,758
-10,000
-6% -$1.73M 11.65% 1
2020
Q4
$23.9M Buy
168,758
+5,392
+3% +$782K 10.31% 1
2020
Q3
$20.4M Sell
163,366
-33,572
-17% -$3.52M 9.67% 1
2020
Q2
$17.6M Sell
196,938
-10,640
-5% -$829K 8.94% 1
2020
Q1
$12.9M Buy
+207,578
New +$16.2M 7.68% 1

Other funds holding TXG